Consistent with pharmacological experimental data, these findings indicate that AR alleviates T2DM-associated inflammation and insulin resistance (IR) by inhibiting lipid peroxidation and suppressing NF-κB-mediated pro-inflammatory cytokine expression. Here, NFKB1 is linked to type 2 diabetes mellitus.